Kyverna Therapeutics, Inc. Common Stock Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2024 | 2 | -$0.84 | -$0.84 | -$0.84 |
| Q2 2024 | 1 | -$0.70 | -$0.70 | -$0.70 |
| Q3 2024 | 4 | -$0.85 | -$0.70 | -$0.79 |
| Q4 2024 | 1 | -$0.93 | -$0.93 | -$0.93 |
| Q1 2025 | 2 | -$0.94 | -$0.94 | -$0.94 |
| Q2 2025 | 2 | -$0.98 | -$0.98 | -$0.98 |
| Q3 2025 | 2 | -$0.88 | -$0.88 | -$0.88 |
| Q4 2025 | 2 | -$0.83 | -$0.83 | -$0.83 |
Kyverna Therapeutics, Inc. Common Stock Earnings Date And Information
Kyverna Therapeutics, Inc. Common Stock last posted its earnings results on Monday, August 12th, 2024. The company reported $-0.67 earnings per share for the quarter, topping analysts' consensus estimates of $-0.7 by $0.03. The company had revenue of 0 for the quarter and had revenue of 0 for the year. Kyverna Therapeutics, Inc. Common Stock has generated $-1 earnings per share over the last year ($-1.48 diluted earnings per share) and currently has a price-to-earnings ratio of -2.12. Kyverna Therapeutics, Inc. Common Stock has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, November 27th, 2024 based on prior year's report dates.
Kyverna Therapeutics, Inc. Common Stock Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 08/12/2024 | Q2 2024 | -$0.70 | -$0.67 | 0.03 | $0 | $0 |
| 05/14/2024 | Q1 2024 | -$0.88 | -$1.12 | -0.24 | $0 | $0 |
| 03/26/2024 | Q4 2023 | -$3.23 | -$0.48 | 2.75 | $0 | |
| 09/29/2023 | Q3 2023 | -$0.36 | $0 | |||
| 06/29/2023 | Q2 2023 | -$0.30 | $0 | |||
| 03/30/2023 | Q1 2023 | -$0.43 | $0 | |||
| 12/30/2022 | Q4 2022 | -$0.20 | $282,000 |
Kyverna Therapeutics, Inc. Common Stock Earnings: Frequently Asked Questions
-
When is Kyverna Therapeutics, Inc. Common Stock's earnings date?
Kyverna Therapeutics, Inc. Common Stock has not confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, November 27th, 2024 based off last year's report dates.
-
Did Kyverna Therapeutics, Inc. Common Stock beat their earnings estimates last quarter?
In the previous quarter, Kyverna Therapeutics, Inc. Common Stock (:KYTX) reported $-0.67 earnings per share (EPS) to beat the analysts' consensus estimate of $-0.7 by $0.03.
-
How can I listen to Kyverna Therapeutics, Inc. Common Stock's earnings conference call?
The conference call for Kyverna Therapeutics, Inc. Common Stock's latest earnings report can be listened to online.
-
How can I read Kyverna Therapeutics, Inc. Common Stock's conference call transcript?
The conference call transcript for Kyverna Therapeutics, Inc. Common Stock's latest earnings report can be read online.
-
How much profit does Kyverna Therapeutics, Inc. Common Stock generate each year?
Kyverna Therapeutics, Inc. Common Stock (:KYTX) has a recorded net income of $0. Kyverna Therapeutics, Inc. Common Stock has generated $-1.48 earnings per share over the last four quarters.
-
What is Kyverna Therapeutics, Inc. Common Stock's price-to-earnings ratio?
Kyverna Therapeutics, Inc. Common Stock (:KYTX) has a price-to-earnings ratio of -2.12 and price/earnings-to-growth ratio is 0.13.
